Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Current practice for the provision of late second trimester abortion (dilation and
evacuation, or D&E) often involves the administration of digoxin into the fetal compartment
to induce fetal demise prior to the procedure. Digoxin may be administered transabdominally
or transvaginally into the fetal compartment. Both modes of administration have been shown in
prospective studies to be highly effective and safe. Both modes of administration are
considered standard of care. This pilot study will directly compare transabdominal and
transvaginal digoxin with respect to patient preference (i.e, patient pain score describing
discomfort with injection).